Security
Token
There is no security token.
Firewall
main
Name
Security enabled
Stateless
Configuration
Key | Value |
---|---|
provider | security.user.provider.concrete.app_user_provider |
context | main |
entry_point | App\Security\KbinAuthenticator |
user_checker | App\Security\UserChecker |
access_denied_handler | (none) |
access_denied_url | (none) |
authenticators | [ "two_factor" "remember_me" "App\Security\KbinAuthenticator" "App\Security\FacebookAuthenticator" "App\Security\GoogleAuthenticator" "App\Security\GithubAuthenticator" "App\Security\KeycloakAuthenticator" ] |
Listeners
Listener | Duration | Response |
---|---|---|
Symfony\Component\Security\Http\Firewall\ChannelListener {#723 -map: Symfony\Component\Security\Http\AccessMap {#722 …} -logger: Monolog\Logger {#783 …} -httpPort: 80 -httpsPort: 443 } |
0.00 ms | (none) |
Symfony\Component\Security\Http\Firewall\ContextListener {#706 -tokenStorage: Symfony\Component\Security\Core\Authentication\Token\Storage\TokenStorage {#1017 …} -sessionKey: "_security_main" -logger: Monolog\Logger {#783 …} -userProviders: Symfony\Component\DependencyInjection\Argument\RewindableGenerator {#705 …} -dispatcher: Symfony\Component\EventDispatcher\Debug\TraceableEventDispatcher {#747 …} -registered: false -trustResolver: Scheb\TwoFactorBundle\Security\Authentication\AuthenticationTrustResolver {#780 …} -sessionTrackerEnabler: Symfony\Component\Security\Core\Authentication\Token\Storage\UsageTrackingTokenStorage::enableUsageTracking(): void {#703 …} } |
0.13 ms | (none) |
Symfony\Component\Security\Http\Firewall\AuthenticatorManagerListener {#584 -authenticatorManager: Symfony\Component\Security\Http\Authentication\AuthenticatorManager {#595 …} } |
0.00 ms | (none) |
Scheb\TwoFactorBundle\Security\Http\Firewall\TwoFactorAccessListener {#582 -twoFactorFirewallConfig: Scheb\TwoFactorBundle\Security\TwoFactor\TwoFactorFirewallConfig {#842 …} -tokenStorage: Symfony\Component\Security\Core\Authentication\Token\Storage\UsageTrackingTokenStorage {#1018 …} -twoFactorAccessDecider: Scheb\TwoFactorBundle\Security\Authorization\TwoFactorAccessDecider {#581 …} } |
0.03 ms | (none) |
Symfony\Component\Security\Http\Firewall\AccessListener {#579 -tokenStorage: Symfony\Component\Security\Core\Authentication\Token\Storage\UsageTrackingTokenStorage {#1018 …} -accessDecisionManager: Symfony\Component\Security\Core\Authorization\TraceableAccessDecisionManager {#937 …} -map: Symfony\Component\Security\Http\AccessMap {#722 …} } |
0.00 ms | (none) |
Symfony\Component\Security\Http\Firewall\LogoutListener {#786 -tokenStorage: Symfony\Component\Security\Core\Authentication\Token\Storage\UsageTrackingTokenStorage {#1018 …} -options: [ "csrf_parameter" => "_csrf_token" "csrf_token_id" => "logout" "logout_path" => "app_logout" ] -httpUtils: Symfony\Component\Security\Http\HttpUtils {#841 …} -csrfTokenManager: Symfony\Component\Security\Csrf\CsrfTokenManager {#1015 …} -eventDispatcher: Symfony\Component\EventDispatcher\Debug\TraceableEventDispatcher {#747 …} } |
0.00 ms | (none) |
Authenticators
No authenticators have been recorded. Check previous profiles on your authentication endpoint.
Access Decision
affirmative
Strategy
Access decision log
# | Result | Attributes | Object | ||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | DENIED | ROLE_USER | null |
||||||||||||||||||||||||
|
|||||||||||||||||||||||||||
2 | DENIED | moderate | App\Entity\EntryComment {#1369 +user: Proxies\__CG__\App\Entity\User {#1370 …} +entry: App\Entity\Entry {#1810 …} +magazine: App\Entity\Magazine {#313 +icon: Proxies\__CG__\App\Entity\Image {#294 …} +name: "mildlyinteresting@lemmy.world" +title: "mildlyinteresting" +description: """ This is for strictly *mildly* interesting material. If it’s too interesting, it doesn’t belong. If it’s not interesting, it doesn’t belong.\n \n This is obviously an objective criteria, so the mods are always right. Or maybe mildly right? Ahh… what do we know?\n \n Just post some stuff and don’t spam. """ +rules: null +subscriptionsCount: 1 +entryCount: 307 +entryCommentCount: 6090 +postCount: 0 +postCommentCount: 0 +isAdult: false +customCss: null +lastActive: DateTime @1729579416 {#323 : 2024-10-22 08:43:36.0 +02:00 } +markedForDeletionAt: null +tags: null +moderators: Doctrine\ORM\PersistentCollection {#285 …} +ownershipRequests: Doctrine\ORM\PersistentCollection {#281 …} +moderatorRequests: Doctrine\ORM\PersistentCollection {#270 …} +entries: Doctrine\ORM\PersistentCollection {#228 …} +posts: Doctrine\ORM\PersistentCollection {#186 …} +subscriptions: Doctrine\ORM\PersistentCollection {#248 …} +bans: Doctrine\ORM\PersistentCollection {#165 …} +reports: Doctrine\ORM\PersistentCollection {#151 …} +badges: Doctrine\ORM\PersistentCollection {#129 …} +logs: Doctrine\ORM\PersistentCollection {#119 …} +awards: Doctrine\ORM\PersistentCollection {#108 …} +categories: Doctrine\ORM\PersistentCollection {#95 …} -id: 20 +apId: "mildlyinteresting@lemmy.world" +apProfileId: "https://lemmy.world/c/mildlyinteresting" +apPublicUrl: "https://lemmy.world/c/mildlyinteresting" +apFollowersUrl: "https://lemmy.world/c/mildlyinteresting/followers" +apInboxUrl: "https://lemmy.world/inbox" +apDomain: "lemmy.world" +apPreferredUsername: "mildlyinteresting" +apDiscoverable: true +apManuallyApprovesFollowers: null +privateKey: null +publicKey: null +apFetchedAt: DateTime @1729563669 {#317 : 2024-10-22 04:21:09.0 +02:00 } +apDeletedAt: null +apTimeoutAt: null +visibility: "visible " +createdAt: DateTimeImmutable @1689840443 {#316 : 2023-07-20 10:07:23.0 +02:00 } } +image: null +parent: Proxies\__CG__\App\Entity\EntryComment {#2451 …} +root: Proxies\__CG__\App\Entity\EntryComment {#2356 …} +body: "Thanks for the well wishes. Also last year I participated in a clinical trial with this same team at the Brigham. The drug trialed there is called bocidelpar. It targets a mitochondrial receptor called PPAR-δ. We’re still waiting on the results of that trial to be released and it’s probably a good 3-5 years away from FDA approval in the US if all goes well. So here’s hoping for the best" +lang: "en" +isAdult: false +favouriteCount: 1 +score: 0 +lastActive: DateTime @1696807551 {#1605 : 2023-10-09 01:25:51.0 +02:00 } +ip: null +tags: null +mentions: [ "@sbv@sh.itjust.works" "@bjoern_tantau@swg-empire.de" "@Chetzemoka@startrek.website" "@Terces@lemmy.world" ] +children: Doctrine\ORM\PersistentCollection {#2466 …} +nested: Doctrine\ORM\PersistentCollection {#2288 …} +votes: Doctrine\ORM\PersistentCollection {#2446 …} +reports: Doctrine\ORM\PersistentCollection {#2439 …} +favourites: Doctrine\ORM\PersistentCollection {#2489 …} +notifications: Doctrine\ORM\PersistentCollection {#60 …} -id: 38070 -bodyTs: "'-5':58 '3':57 'also':6 'approv':63 'away':60 'best':77 'bocidelpar':28 'brigham':21 'call':27,34 'clinic':13 'drug':23 'fda':62 'goe':69 'good':56 'hope':74 'last':7 'mitochondri':32 'particip':10 'ppar':36 'ppar-δ':35 'probabl':54 're':39 'receptor':33 'releas':50 'result':44 'still':40 'target':30 'team':18 'thank':1 'trial':14,24,47 'us':66 'wait':41 'well':4,70 'wish':5 'year':8,59 'δ':37" +ranking: 0 +commentCount: 0 +upVotes: 0 +downVotes: 0 +visibility: "visible " +apId: "https://startrek.website/comment/3134302" +editedAt: DateTimeImmutable @1696807561 {#1945 : 2023-10-09 01:26:01.0 +02:00 } +createdAt: DateTimeImmutable @1696807551 {#1368 : 2023-10-09 01:25:51.0 +02:00 } } |
||||||||||||||||||||||||
|
|||||||||||||||||||||||||||
3 | DENIED | edit | App\Entity\EntryComment {#1369 +user: Proxies\__CG__\App\Entity\User {#1370 …} +entry: App\Entity\Entry {#1810 …} +magazine: App\Entity\Magazine {#313 +icon: Proxies\__CG__\App\Entity\Image {#294 …} +name: "mildlyinteresting@lemmy.world" +title: "mildlyinteresting" +description: """ This is for strictly *mildly* interesting material. If it’s too interesting, it doesn’t belong. If it’s not interesting, it doesn’t belong.\n \n This is obviously an objective criteria, so the mods are always right. Or maybe mildly right? Ahh… what do we know?\n \n Just post some stuff and don’t spam. """ +rules: null +subscriptionsCount: 1 +entryCount: 307 +entryCommentCount: 6090 +postCount: 0 +postCommentCount: 0 +isAdult: false +customCss: null +lastActive: DateTime @1729579416 {#323 : 2024-10-22 08:43:36.0 +02:00 } +markedForDeletionAt: null +tags: null +moderators: Doctrine\ORM\PersistentCollection {#285 …} +ownershipRequests: Doctrine\ORM\PersistentCollection {#281 …} +moderatorRequests: Doctrine\ORM\PersistentCollection {#270 …} +entries: Doctrine\ORM\PersistentCollection {#228 …} +posts: Doctrine\ORM\PersistentCollection {#186 …} +subscriptions: Doctrine\ORM\PersistentCollection {#248 …} +bans: Doctrine\ORM\PersistentCollection {#165 …} +reports: Doctrine\ORM\PersistentCollection {#151 …} +badges: Doctrine\ORM\PersistentCollection {#129 …} +logs: Doctrine\ORM\PersistentCollection {#119 …} +awards: Doctrine\ORM\PersistentCollection {#108 …} +categories: Doctrine\ORM\PersistentCollection {#95 …} -id: 20 +apId: "mildlyinteresting@lemmy.world" +apProfileId: "https://lemmy.world/c/mildlyinteresting" +apPublicUrl: "https://lemmy.world/c/mildlyinteresting" +apFollowersUrl: "https://lemmy.world/c/mildlyinteresting/followers" +apInboxUrl: "https://lemmy.world/inbox" +apDomain: "lemmy.world" +apPreferredUsername: "mildlyinteresting" +apDiscoverable: true +apManuallyApprovesFollowers: null +privateKey: null +publicKey: null +apFetchedAt: DateTime @1729563669 {#317 : 2024-10-22 04:21:09.0 +02:00 } +apDeletedAt: null +apTimeoutAt: null +visibility: "visible " +createdAt: DateTimeImmutable @1689840443 {#316 : 2023-07-20 10:07:23.0 +02:00 } } +image: null +parent: Proxies\__CG__\App\Entity\EntryComment {#2451 …} +root: Proxies\__CG__\App\Entity\EntryComment {#2356 …} +body: "Thanks for the well wishes. Also last year I participated in a clinical trial with this same team at the Brigham. The drug trialed there is called bocidelpar. It targets a mitochondrial receptor called PPAR-δ. We’re still waiting on the results of that trial to be released and it’s probably a good 3-5 years away from FDA approval in the US if all goes well. So here’s hoping for the best" +lang: "en" +isAdult: false +favouriteCount: 1 +score: 0 +lastActive: DateTime @1696807551 {#1605 : 2023-10-09 01:25:51.0 +02:00 } +ip: null +tags: null +mentions: [ "@sbv@sh.itjust.works" "@bjoern_tantau@swg-empire.de" "@Chetzemoka@startrek.website" "@Terces@lemmy.world" ] +children: Doctrine\ORM\PersistentCollection {#2466 …} +nested: Doctrine\ORM\PersistentCollection {#2288 …} +votes: Doctrine\ORM\PersistentCollection {#2446 …} +reports: Doctrine\ORM\PersistentCollection {#2439 …} +favourites: Doctrine\ORM\PersistentCollection {#2489 …} +notifications: Doctrine\ORM\PersistentCollection {#60 …} -id: 38070 -bodyTs: "'-5':58 '3':57 'also':6 'approv':63 'away':60 'best':77 'bocidelpar':28 'brigham':21 'call':27,34 'clinic':13 'drug':23 'fda':62 'goe':69 'good':56 'hope':74 'last':7 'mitochondri':32 'particip':10 'ppar':36 'ppar-δ':35 'probabl':54 're':39 'receptor':33 'releas':50 'result':44 'still':40 'target':30 'team':18 'thank':1 'trial':14,24,47 'us':66 'wait':41 'well':4,70 'wish':5 'year':8,59 'δ':37" +ranking: 0 +commentCount: 0 +upVotes: 0 +downVotes: 0 +visibility: "visible " +apId: "https://startrek.website/comment/3134302" +editedAt: DateTimeImmutable @1696807561 {#1945 : 2023-10-09 01:26:01.0 +02:00 } +createdAt: DateTimeImmutable @1696807551 {#1368 : 2023-10-09 01:25:51.0 +02:00 } } |
||||||||||||||||||||||||
|
|||||||||||||||||||||||||||
4 | DENIED | moderate | App\Entity\EntryComment {#1369 +user: Proxies\__CG__\App\Entity\User {#1370 …} +entry: App\Entity\Entry {#1810 …} +magazine: App\Entity\Magazine {#313 +icon: Proxies\__CG__\App\Entity\Image {#294 …} +name: "mildlyinteresting@lemmy.world" +title: "mildlyinteresting" +description: """ This is for strictly *mildly* interesting material. If it’s too interesting, it doesn’t belong. If it’s not interesting, it doesn’t belong.\n \n This is obviously an objective criteria, so the mods are always right. Or maybe mildly right? Ahh… what do we know?\n \n Just post some stuff and don’t spam. """ +rules: null +subscriptionsCount: 1 +entryCount: 307 +entryCommentCount: 6090 +postCount: 0 +postCommentCount: 0 +isAdult: false +customCss: null +lastActive: DateTime @1729579416 {#323 : 2024-10-22 08:43:36.0 +02:00 } +markedForDeletionAt: null +tags: null +moderators: Doctrine\ORM\PersistentCollection {#285 …} +ownershipRequests: Doctrine\ORM\PersistentCollection {#281 …} +moderatorRequests: Doctrine\ORM\PersistentCollection {#270 …} +entries: Doctrine\ORM\PersistentCollection {#228 …} +posts: Doctrine\ORM\PersistentCollection {#186 …} +subscriptions: Doctrine\ORM\PersistentCollection {#248 …} +bans: Doctrine\ORM\PersistentCollection {#165 …} +reports: Doctrine\ORM\PersistentCollection {#151 …} +badges: Doctrine\ORM\PersistentCollection {#129 …} +logs: Doctrine\ORM\PersistentCollection {#119 …} +awards: Doctrine\ORM\PersistentCollection {#108 …} +categories: Doctrine\ORM\PersistentCollection {#95 …} -id: 20 +apId: "mildlyinteresting@lemmy.world" +apProfileId: "https://lemmy.world/c/mildlyinteresting" +apPublicUrl: "https://lemmy.world/c/mildlyinteresting" +apFollowersUrl: "https://lemmy.world/c/mildlyinteresting/followers" +apInboxUrl: "https://lemmy.world/inbox" +apDomain: "lemmy.world" +apPreferredUsername: "mildlyinteresting" +apDiscoverable: true +apManuallyApprovesFollowers: null +privateKey: null +publicKey: null +apFetchedAt: DateTime @1729563669 {#317 : 2024-10-22 04:21:09.0 +02:00 } +apDeletedAt: null +apTimeoutAt: null +visibility: "visible " +createdAt: DateTimeImmutable @1689840443 {#316 : 2023-07-20 10:07:23.0 +02:00 } } +image: null +parent: Proxies\__CG__\App\Entity\EntryComment {#2451 …} +root: Proxies\__CG__\App\Entity\EntryComment {#2356 …} +body: "Thanks for the well wishes. Also last year I participated in a clinical trial with this same team at the Brigham. The drug trialed there is called bocidelpar. It targets a mitochondrial receptor called PPAR-δ. We’re still waiting on the results of that trial to be released and it’s probably a good 3-5 years away from FDA approval in the US if all goes well. So here’s hoping for the best" +lang: "en" +isAdult: false +favouriteCount: 1 +score: 0 +lastActive: DateTime @1696807551 {#1605 : 2023-10-09 01:25:51.0 +02:00 } +ip: null +tags: null +mentions: [ "@sbv@sh.itjust.works" "@bjoern_tantau@swg-empire.de" "@Chetzemoka@startrek.website" "@Terces@lemmy.world" ] +children: Doctrine\ORM\PersistentCollection {#2466 …} +nested: Doctrine\ORM\PersistentCollection {#2288 …} +votes: Doctrine\ORM\PersistentCollection {#2446 …} +reports: Doctrine\ORM\PersistentCollection {#2439 …} +favourites: Doctrine\ORM\PersistentCollection {#2489 …} +notifications: Doctrine\ORM\PersistentCollection {#60 …} -id: 38070 -bodyTs: "'-5':58 '3':57 'also':6 'approv':63 'away':60 'best':77 'bocidelpar':28 'brigham':21 'call':27,34 'clinic':13 'drug':23 'fda':62 'goe':69 'good':56 'hope':74 'last':7 'mitochondri':32 'particip':10 'ppar':36 'ppar-δ':35 'probabl':54 're':39 'receptor':33 'releas':50 'result':44 'still':40 'target':30 'team':18 'thank':1 'trial':14,24,47 'us':66 'wait':41 'well':4,70 'wish':5 'year':8,59 'δ':37" +ranking: 0 +commentCount: 0 +upVotes: 0 +downVotes: 0 +visibility: "visible " +apId: "https://startrek.website/comment/3134302" +editedAt: DateTimeImmutable @1696807561 {#1945 : 2023-10-09 01:26:01.0 +02:00 } +createdAt: DateTimeImmutable @1696807551 {#1368 : 2023-10-09 01:25:51.0 +02:00 } } |
||||||||||||||||||||||||
|
|||||||||||||||||||||||||||
5 | DENIED | edit | App\Entity\Magazine {#313 +icon: Proxies\__CG__\App\Entity\Image {#294 …} +name: "mildlyinteresting@lemmy.world" +title: "mildlyinteresting" +description: """ This is for strictly *mildly* interesting material. If it’s too interesting, it doesn’t belong. If it’s not interesting, it doesn’t belong.\n \n This is obviously an objective criteria, so the mods are always right. Or maybe mildly right? Ahh… what do we know?\n \n Just post some stuff and don’t spam. """ +rules: null +subscriptionsCount: 1 +entryCount: 307 +entryCommentCount: 6090 +postCount: 0 +postCommentCount: 0 +isAdult: false +customCss: null +lastActive: DateTime @1729579416 {#323 : 2024-10-22 08:43:36.0 +02:00 } +markedForDeletionAt: null +tags: null +moderators: Doctrine\ORM\PersistentCollection {#285 …} +ownershipRequests: Doctrine\ORM\PersistentCollection {#281 …} +moderatorRequests: Doctrine\ORM\PersistentCollection {#270 …} +entries: Doctrine\ORM\PersistentCollection {#228 …} +posts: Doctrine\ORM\PersistentCollection {#186 …} +subscriptions: Doctrine\ORM\PersistentCollection {#248 …} +bans: Doctrine\ORM\PersistentCollection {#165 …} +reports: Doctrine\ORM\PersistentCollection {#151 …} +badges: Doctrine\ORM\PersistentCollection {#129 …} +logs: Doctrine\ORM\PersistentCollection {#119 …} +awards: Doctrine\ORM\PersistentCollection {#108 …} +categories: Doctrine\ORM\PersistentCollection {#95 …} -id: 20 +apId: "mildlyinteresting@lemmy.world" +apProfileId: "https://lemmy.world/c/mildlyinteresting" +apPublicUrl: "https://lemmy.world/c/mildlyinteresting" +apFollowersUrl: "https://lemmy.world/c/mildlyinteresting/followers" +apInboxUrl: "https://lemmy.world/inbox" +apDomain: "lemmy.world" +apPreferredUsername: "mildlyinteresting" +apDiscoverable: true +apManuallyApprovesFollowers: null +privateKey: null +publicKey: null +apFetchedAt: DateTime @1729563669 {#317 : 2024-10-22 04:21:09.0 +02:00 } +apDeletedAt: null +apTimeoutAt: null +visibility: "visible " +createdAt: DateTimeImmutable @1689840443 {#316 : 2023-07-20 10:07:23.0 +02:00 } } |
||||||||||||||||||||||||
|